Genetic polymorphism of Thymidylate Synthase Enhancer Region (TSER) in Korean

Korean Journal of Genetics

Volumn 25, Issue 4, 2003, Pages 287-291

  Kim, Jin Kyeoung ^a   Oh, Doyeun ^a   Cho, Sung Hoon ^a   Kim, Ok Jun ^a   Cho, Yun Kyung ^a   Kim, Sun Hee ^a   Kang, You Jung ^a   Ahn, Jung Yong ^a   Hwang, Seong Gyu ^a   Cha, Kwang Yul ^a   Kim, Nam Keun ^a  

^a CHA University   (South Korea)

Author keywords

Ethinic group; Korean population; Polymorphism; Thymidylate synthase enhancer region

Indexed keywords

GENOMIC DNA; THYMIDYLATE SYNTHASE;

ARTICLE; ASIAN; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; ENHANCER REGION; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALE;

EID: 13444279404     PISSN: 02545934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Berglund A, Edler D, Molin D, Nordlinder H, Graf W and Glimelius B (2002) Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma. Anticancer Res. 22(6B): 3653-3659.
2. Dong S, Lester L and Johnson LF (2000) Transcriptional control elements and complex initiation pattern of the TATA-less bidirectional human thymidylate synthase promoter. J. Cell. Biochem. 77: 50-64.
3. Gonen M, Hummer A, Zervoudakis A, Sullivan D, Fong Y, Banerjee D, Klimstra D, Cordon-Cardo C, Bertino J and Kemeny N (2003) Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer. J. Clin. Oncol. 21: 406-412.
4. Hishida A, Matsuo K, Hamajima N, Ito H, Ogura M, Kagami Y, Taji H, Morishima Y, Emi N and Tajima K (2003) Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica 88: 159-166.
5. Horie N, Aiba H, Oguro K, Hojo H and Takeishi K (1995) Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct. Funct. 20: 191-197.
6. Horie N and Takeishi K (1995) Functional structure of the promoter region of the human thymidylate synthase gene and nuclear factors that regulate the expression of the gene. Nucleic Acids Symp. Ser. 34: 77-78.
7. Horie N and Takeishi K (1997) Identification of functional elements in the promoter region of the human gene for thymidylate synthase and nuclear factors that regulate the expression of the gene. J. Biol. Chem. 272: 18375-18381.
8. Hwang HS, Hwang JH, Shin SH, Kim HS, Kim NK, Kim SJ and Chung KW (2001) Genetic polymorphisms of p53 tumor suppressor gene in Korean population. Korean J. Genetics 23: 227-232.
9. Johnston PG, Benson AB 3rd, Catalano P, Rao MS, O'Dwyer PJ and Allegra CJ (2003) Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites. J. Clin. Oncol. 21: 815-819.
10. Kaneda S, Takeishi K, Ayusawa D, Shimizu K, Seno T and Altman S (1987) Role in translation of a triple tandemly repeated sequence in the 5′-untranslated region of human thymidylate synthase mRNA. Nucleic Acids Res. 15: 1259-1270.
11. Kawakami K, Omura K, Kanehira E and Watanabe Y (1999) Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. Anticancer Res. 19(4B): 3249-3252.
12. Kim NK, Kang GD, Kim HJ, Kim SH, Nam YS, Lee S, Chung HM, Kang SH, Ahn JY, Choi BO, Hwang SG and Oh D (2002) Genetic polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) in healthy Korean. Korean J. Genetics 24: 227-234.
13. Leichman CG, Lenz HJ, Leichman L, Danenberg K, Baranda J, Groshen S, Boswell W, Metzger R, Tan M and Danenberg PV (1997) Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J. Clin. Oncol. 15: 3223-3229.
14. Luo HR, Lu XM, Yao YG, Horie N, Takeishi K, Jorde LB and Zhang YP (2002) Length polymorphism of thymidylate synthase regulatory region in Chinese populations and evolution of the novel alleles. Biochem. Genet. 40(1-2): 41-51.
15. Marsh S, Collie-Duguid ES, Li T, Liu X and McLeod HL (1999) Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations. Genomics 58: 310-312.
16. Marsh S, Ameyaw MM, Githang'a J, Indalo A, Ofori-Adjei D and McLeod HL (2000) Novel thymidylate synthase enhancer region alleles in African populations. Hum. Mutat. 16: 528.
17. Pullarkat ST, Stoehlmacher J, Ghaderi V, Xiong YP, Ingles SA, Sherrod A, Warren R, Tsao-Wei D, Groshen S and Lenz HJ (2001) Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics J. 1: 65-70.
18. Rustum YM, Harstrick A, Cao S, Vanhoefer U, Yin MB, Wilke H and Seeber S (1997) Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors. J. Clin. Oncol. 15: 389-400.
19. Sunamura M, Oonuma M, Motoi F, Abe H, Saitoh Y, Hoshida T, Ottomo S, Horii A and Matsuno S (2002) Gene therapy for pancreatic cancer targeting the genomic alterations of tumor suppressor genes using replication-selective oncolytic adenovirus. Hum. Cell 15: 138-150.